← back to search

Shisan Bao

UNSW Sydney · AU
Area of research
Epidemiology · Immunology
Research interest
Research interests include Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Hepatitis C virus research, and Immune Response and Inflammation.
h-index
48
citations
8,821
works
290
NIH funding
primary concept
email

Recent publications

Predicting hearing loss in noise-exposed petrochemical workers: Influencing factors and a nomogram model
Public Health in Practice 2026cited by 0position: contributordoi
RBM10 inhibits pancreatic cancer development by suppressing immune escape through PD-1 expression
Journal of Cancer 2025cited by 1position: middledoi
Emerging cytokines contribute to the clinical manifestation of carotid artery plaque formation and stability in patients with diabetes
Atherosclerosis Plus 2025cited by 1position: contributordoi
Unravelling key genes and molecular pathways in gastric inflammation-to-cancer transition through causal discovery: implications for early diagnosis and therapy.
2025cited by 0position: contributordoi
Unveiling COVID-19 lockdowns shaped the growth of Chinese preschool children.
2025cited by 0position: contributordoi
The impact of COVID-19 on referrals among general practitioners and specialists in Shanghai, China.
2024cited by 1position: contributordoi
The Pro-Tumor Biological Function of IL-36α Plays an Important Role in the Tumor Microenvironment of HCC.
2023cited by 7position: contributordoi
The outcomes of lockdown in the higher education sector during the COVID-19 pandemic.
2023cited by 5position: contributordoi
The impact of COVID-19 lockdown on nursing higher education at Chengdu University.
2023cited by 4position: contributordoi
Hepatotoxicity Following Immune Checkpoint Inhibitor Therapy in Metastatic Lung Adenocarcinoma: A Case Report
2022cited by 0position: contributordoi
The Impact of COVID-19 on Primary Care General Practice Consultations in a Teaching Hospital in Shanghai, China
Frontiers in Medicine 2021cited by 37position: lastdoi
miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis
OncoTargets and Therapy 2021cited by 28position: middledoi
Comparison between Acupuncture and Nicotine Replacement Therapies for Smoking Cessation Based on Randomized Controlled Trials: A Systematic Review and Bayesian Network Meta-Analysis.
2021cited by 11position: contributordoi
Simultaneous compound disasters from <scp>COVID</scp>‐19 and catastrophic flooding
Journal of Flood Risk Management 2021cited by 4position: contributordoi
Bibliometric Analysis on COVID-19: A Comparison of Research Between English and Chinese Studies
Frontiers in Public Health 2020cited by 134position: lastdoi
Epidemiology of Coronavirus Disease in Gansu Province, China, 2020
Emerging infectious diseases 2020cited by 123position: lastdoi
IL-34, IL-36 and IL-38 in colorectal cancer—key immunoregulators of carcinogenesis
Biophysical Reviews 2020cited by 41position: firstdoi
IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
2020cited by 26position: contributordoi
Interleukin-38 in colorectal cancer: a potential role in precision medicine.
2020cited by 25position: contributordoi
IL-34, IL-36 and IL-38 in colorectal cancer-key immunoregulators of carcinogenesis.
2020cited by 23position: contributordoi
Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis.
2020cited by 15position: contributordoi
Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.
2020cited by 12position: contributordoi
Immobilized Macrophage Colony-Stimulating Factor (M-CSF) Regulates the Foreign Body Response to Implanted Materials.
2020cited by 11position: contributordoi
Professor Cristobal G dos Remedios mentorship.
2020cited by 1position: contributordoi
Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis
2020cited by 0position: contributordoi
Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis
2020cited by 0position: contributordoi
N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus.
2019cited by 11position: contributordoi
Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury
Theranostics 2018cited by 64position: middledoi
Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients
Infection and Drug Resistance 2018cited by 32position: middledoi
Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic <scp>HBV</scp> infection
Liver International 2017cited by 52position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 21 papers (2019–2026)Brett D. Hambly · The University of Sydney5 papers (2012–2021)Hui Wang · Fudan University4 papers (2015–2018)Ruidong Mo · Guangzhou Medical University3 papers (2015–2018)Weiliang Tang · Shaoxing People's Hospital3 papers (2012–2018) · 3 papers (2015–2018) · 3 papers (2017–2018)Jingchun Fan · Nanjing Normal University3 papers (2020–2021)Qing Xie · Tongji University3 papers (2017–2018)Marcela Bilek · The University of Sydney2 papers (2012–2014)Yuhan Liu · Electric Power University2 papers (2017–2018)Ziqiang Li · Shandong University2 papers (2017–2018)Buchu Wu · Shanghai Jiao Tong University2 papers (2012–2012)Peipei Ren · Zhejiang University2 papers (2017–2018)Che Chen · Nanjing University of Chinese Medicine2 papers (2020–2021) · 2 papers (2015–2017)Jie Lu · Fudan University2 papers (2017–2018)Yumin Xu · Nantong University2 papers (2017–2018) · 2 papers (2020–2022) · 2 papers (2021–2023)